中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

已选(0)清除 条数/页：   排序方式：
A new prognostic histopathologic classification of nasopharyngeal carcinoma 期刊论文
CHINESE JOURNAL OF CANCER, 2016, 卷号: 35
-
收藏  |  浏览/下载：26/0  |  提交时间：2020/10/26
CONCURRENT CISPLATIN-RADIOTHERAPY  ADJUVANT CHEMOTHERAPY  RANDOMIZED-TRIAL  STAGING SYSTEM  CANCER  CHEMORADIOTHERAPY  METAANALYSIS  CHINA  SURVIVAL  UNION  Nasopharyngeal carcinoma  Pathologic classification  Prognosis  
Risk factors associated with postoperative hospital stay after pancreaticoduodenectomy: a retrospective study 期刊论文
CHINESE MEDICAL JOURNAL, 2013, 卷号: 126
-
收藏  |  浏览/下载：28/0  |  提交时间：2020/10/26
PROSPECTIVE RANDOMIZED-TRIAL  INTERNATIONAL STUDY-GROUP  DUCT-TO-MUCOSA  PANCREATICOJEJUNOSTOMY RECONSTRUCTION  PANCREATIC LEAKAGE  SURGICAL OUTCOMES  SURGERY  METAANALYSIS  COMPLICATIONS  HEMORRHAGE  length of stay  pancreaticoduodenectomy  postoperative period  risk factors  
Chemotherapy with or without gefitinib in patients with advanced non-small-cell lung cancer: a meta-analysis of 6844 patients 期刊论文
CHINESE MEDICAL JOURNAL, 2013, 卷号: 126
-
收藏  |  浏览/下载：27/0  |  提交时间：2020/10/26
PHASE-III TRIAL  PLATINUM-BASED CHEMOTHERAPY  PREVIOUSLY TREATED PATIENTS  JAPANESE PATIENTS  RANDOMIZED-TRIAL  SUPPORTIVE CARE  NAIVE PATIENTS  DOCETAXEL  PLACEBO  MULTICENTER  non-small-cell-lung cancer  gefitinib  meta-analysis  
Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study 期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 卷号: 17
-
收藏  |  浏览/下载：25/0  |  提交时间：2020/10/26
GROWTH-FACTOR-RECEPTOR  PHASE-II TRIAL  FLUOROURACIL FAILURE  1ST-LINE TREATMENT  RANDOMIZED-TRIAL  CHEMOTHERAPY  OXALIPLATIN  EXPRESSION  INFUSION  SURVIVAL  Epidermal growth factor receptor  Cetuximab  Irinotecan  Metastatic colorectal cancer  Asia